BofA Securities Downgrades Kymera Therapeutics (KYMR) to Neutral, 'limited NT catalysts'
Tweet Send to a Friend
(Updated - January 3, 2024 7:41 AM EST)
BofA Securities analyst Geoff Meacham downgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Geoff Meacham downgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
